BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
The Beauty Health Company (SKIN) PT Raised to $3 at Piper Sandler
March 13, 2024 6:42 AM EDTPiper Sandler analyst Korinne Wolfmeyer raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $3.00 (from $2.00) while maintaining a Underweight rating.
The analyst comments "Both the device and operational issues SKIN is facing don't necessarily seem to be in the... More
The Beauty Health Company (SKIN) PT Raised to $4 at TD Cowen
March 13, 2024 6:07 AM EDTTD Cowen analyst Oliver Chen raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $4.00 (from $2.50) while maintaining a Market Perform rating.
The analyst comments "4Q23 EPS and FY24 guide were better than feared and with a 2H weighted... More
The Beauty Health Company (SKIN) PT Raised to $4 at Stifel
March 13, 2024 4:34 AM EDTStifel analyst Jonathan Block raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $4.00 (from $3.00) while maintaining a Hold rating.
The analyst comments "In our opinion, 4Q23 offered few surprises (recall, components of 4Q23 were already preannounced). Revenue of... More
The Beauty Health Company (SKIN) Reports In-Line Q4 EPS
March 12, 2024 4:15 PM EDTThe Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $96.8 million versus the consensus estimate of $87.22 million.
GUIDANCE:
The Beauty Health Company sees Q1 2024 revenue of $77-83... More
